Prostigmin 12,5 mg/5 mL Soluzione iniettabile

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

neostigmini metilsulfas

MAH:

MEDA Pharmaceuticals Switzerland GmbH

ATC_code:

N07AA01

INN:

neostigmini metilsulfas

pharmaceutical_form:

Soluzione iniettabile

composition:

neostigmini metilsulfas 12.5 mg, natrii chloridum, conserv.: phenolum 20 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Cholinergicum, Antimyasthenicum

authorization_status:

zugelassen

authorization_date:

1952-04-25